Insiders / Rubin Steven D
Rubin Steven D
CIK 1381874personinsider
Companies
5
First seen
Jan 13, 2026
Last activity
Jun 26, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Red Violet, Inc. · RDVT | 147,767 | — |
| Eloxx Pharmaceuticals, Inc. · ELOX | 14,625 | — |
| Entera Bio Ltd. · ENTX | — | — |
| Niagen Bioscience, Inc. · NAGE | — | — |
| Opko Health, Inc. · COCP | — | — |
All securities held
7 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Eloxx Pharmaceuticals, Inc. | Common Stock | 14,625 |
| Eloxx Pharmaceuticals, Inc. | Stock Option (Right to Buy)Derivative | 4,018 |
| Eloxx Pharmaceuticals, Inc. | Restricted Stock UnitsDerivative | 1,875 |
| Entera Bio Ltd. | Ordinary Shares, par value NIS 0.0000769 per share | 15,000 |
| Niagen Bioscience, Inc. | Stock Option (right to buy)Derivative | 31,746 |
| Opko Health, Inc. | Stock Options (Right to Buy)Derivative | 16,410 |
| Red Violet, Inc. | Common Stock | 147,767 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | Buy | ENTX Entera Bio Ltd. Ordinary Shares, par value NIS 0.0000769 per share | $12.0K | +10K | 10,000 <0.01% of shares | low |
| Feb 12, 2026 | Buy | ENTX Entera Bio Ltd. Ordinary Shares, par value NIS 0.0000769 per share | $7.5K | +5K +50.00% | 15,000 <0.01% of shares | low |
| Jun 24, 2026 | Grant | NAGE Niagen Bioscience, Inc. Stock Option (right to buy) | — | +32K | 31,746 0.04% of shares | low |
| Jun 4, 2026 | Grant | RDVT Red Violet, Inc. Common Stock | — | +2K +1.50% | 147,767 0.92% of shares | low |
| Jun 8, 2026 | Grant | ELOX Eloxx Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +4K | 4,018 0.10% of shares | low |
| Jan 24, 2026 | Exercise | ELOX Eloxx Pharmaceuticals, Inc. Restricted Stock Units | — | -2K -50.00% | 1,875 0.05% of shares | low |
| Sep 19, 2025 | Grant | ELOX Eloxx Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +180K | 179,854 4.46% of shares | low |
| Jan 24, 2026 | Exercise | ELOX Eloxx Pharmaceuticals, Inc. Common Stock | — | +2K +14.71% | 14,625 0.36% of shares | low |
| Jan 9, 2026 | Grant | COCP Opko Health, Inc. Stock Options (Right to Buy) | — | +16K | 16,410 0.09% of shares | low |